HTG Molecular Diagnostics Inc HTGM shares are trading higher by 58.06% to $4.90 Tuesday afternoon after the company announced the closing of a $10 million offering.
The company intends to use the net proceeds from this offering for general corporate purposes, which may include research and development expenses, clinical trial expenses, capital expenditures and working capital.
The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are approximately $10 million.
According to data from Benzinga Pro, HTGM has a 52-week high of $68.16 and a 52-week low of $2.38.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
